BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2012
View Archived Issues
Citrulline could serve as a new biomarker of Leigh's disease
Read More
U.S. researchers prepare new antimicrobial agents
Read More
Nerviano Medical Sciences presents novel B-raf inhibitors
Read More
Promising in vitro and in vivo results reported for novel dual c-Met/Ron inhibitor
Read More
New GlyT-1 inhibitors disclosed by Taisho Pharmaceutical
Read More
Phase IIb study confirms feasibility of safe vaccination against dengue
Read More
Novel topical antiviral plant extract for HSV
Read More
Janssen Pharmaceutica patents new alpha7 receptor modulators
Read More
Novel nicotinic acetylcholine alpha7 receptor modulators disclosed by Lupin
Read More
Trana Discovery identifies antibacterial target tRNA
Read More
Bionomics acquires Biogen's oncology spin-off
Read More
JASPAC1 01 phase III interim study results to be published
Read More
TB Alliance presents data for their next-generation tuberculosis drug candidate
Read More
Sunovion Pharmaceuticals launches Latuda in Canada
Read More
Targacept discontinues development of ADHD drug candidate
Read More
Life Technologies and Bristol-Myers Squibb collaborate on companion diagnostics
Read More
Merck KGaA voluntarily withdraws European application for Erbitux in NSCLC
Read More
Vasopharm's VAS-203 demonstrates safety and efficacy in traumatic brain injury trial
Read More
Ablynx reports clinical results for inhaled Nanobody in RSV infection
Read More
New NIH clinical trial network commences trial in spinal muscular atrophy
Read More
Novel mGlu5 receptor PAM developed by Janssen for the treatment of schizophrenia
Read More
Immune Targeting Systems reports clinical data for influenza A vaccine
Read More
Anthera to advance blisibimod into phase III development
Read More
Rib-X Pharmaceuticals' delafloxacin awarded QIDP status
Read More
NIH awards grant to fund research of allosteric inhibitors in acute lung injury
Read More